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Abstract 
Objectives 
Study objectives were to: (1) Determine the value of a COVID-19 universal preprocedural 
screening program; and (2) Using the results of asymptomatic positive screens, determine the 
safety of resuming elective procedures.  
 Design 
This was a descriptive study detailing the process and findings from implementation of a 
COVID-19 universal preprocedural screening program. 
Setting 
An adult academic tertiary center in Indiana. 
Patients 
Patients were included in the analysis if they were screened 96 hours prior to or within 24 hours 
after undergoing a procedure in the operating room, cardiac catheterization lab, or endoscopy. 
Methods 
A report was generated from the electronic health record of patients undergoing procedures from 




, 2020). Health records for positive screens were
reviewed and classified as symptomatic if they met either criteria: (1) screen performed due to 
presence of COVID-19 symptoms; (2) documentation of symptoms at the time of the screen. 
Patients with a positive screen that did not meet symptomatic criteria were classified as 
asymptomatic. Descriptive statistics were used to calculate frequencies and percentages for the 
included sample. 
Results 
The initial sample included 2,194 patients, comprised of 46 positive and 2,148 negative screens. 
Out of the 46 patients who had a positive test, 17 were asymptomatic, resulting in an 
asymptomatic rate of 0.79% (17/2165). 
Conclusion 
Findings validated the value of the program through identification of a low rate of asymptomatic 
positive screens and procedural team adoption and sustainment. Findings may help inform 
decision making of like organizations attempting to enhance safety while resuming elective 
procedures. 
Introduction 
The novel coronavirus 2019 (COVID-19) has caused a global pandemic, placing 
unprecedented strain on the United States (U.S.) healthcare system. In order to preserve the 
safety of hospital staff and patients during the pandemic, the U.S. Department of Health and 
Human Services and the American College of Surgeons issued a guidance for hospitals and 
healthcare systems to postpone elective procedures on March 12, 2020.
2
 Similar guidance
followed from the U.S. Surgeon General and the U.S. Centers for Medicare and Medicaid 
Services, operationalized by individual states.
3,4
 Decreased surgical capacity from COVID-19
has impacted healthcare economic and patient outcomes. As a frame of reference, deferred 
elective surgical activity in 2003 during the severe acute respiratory syndrome (SARS) pandemic 
resulted in an estimated $32.1 million in direct cost to hospitals in the Toronto/Greater Toronto 
Area
5
 and uninteded consequences, such as seriously ill patients not seeking care.
6
As states have gradually allowed elective procedures to resume in the U.S., healthcare 
organizations have been responsible for mitigating spread of SARS-CoV-2, the virus that causes 
COVID-19. In particular, while there is recognition of the importance of screening all patients 
with and without symptoms, some may question the value of universal screening given economic 
and operational considerations. 
Study aims were to: (1) determine the value of universal preprocedural screening for a 
representative academic health center; and (2) using the volume of asymptomatic positive 
screens, determine the safety of resuming elective procedures.    
Methods 
This descriptive study included patients undergoing procedures in the operating room, 
cardiac catheterization lab, and endoscopy at a public adult academic tertiary referral center in 
Indiana. Patients were included in the sample if they had a COVID-19 screen performed within 
96 hours of a scheduled elective procedure or within 24 hours after an emergent procedure. 
Patients were classified as symptomatic if they met either of the following criteria: (1) screen 
performed due to presence of COVID-19 symptoms
7
; (2) documentation of COVID-19
symptoms in the electronic medical record at the time of the screen. Patients with a positive 
screen that did not meet symptomatic criteria were classified as asymptomatic.  
A preprocedural screening program was implemented on May 4, 2020, recommending 
screening within 96 hours of a scheduled procedure. Screening involved a real-time polymerase 
chain reaction (RT-PCR) test collected by oropharyngeal and nasopharyngeal swab. Patients 
with a positive or pending result were rescheduled, unless considered emergent. In the event of 
an emergent case, COVID-19 isolation precautions were implemented. Standard precautions 
were followed for patients with a negative screen unless the patient had symptoms and the 
proceduralist had concern for a false negative screen.  
An infection prevention (IP) data analyst generated a report from the electronic health 
record for patients undergoing procedures for a six week period of time from May 4
th
 - June 14
th
,
2020. An IP and a registered nurse (RN) independently conducted manual chart reviews to verify 
inclusion criteria, screening result, and categorize patients with positive screens as symptomatic 
or asymptomatic. The IP and RN then cross-verified the manual chart reviews to reach 
consensus, and any discrepancies were resolved by consultation with a third reviewer (an 
infectious disease physician). Patients meeting symptomatic criteria were excluded from the 
analysis. Descriptive statistics were used to calculate frequencies and percentages for the 
included sample of patients.  
Results 
The initial sample included 2,194 patients, comprised of 46 positive and 2,148 negative 
screens. Of the 46 positive screens, 29 patients met symptomatic criteria, and were excluded 
from the sample, leaving a final sample of 2,165 patients. The remaining 17 patients were 
verified as asymptomatic positive screens, resulting in a rate of 0.79% (17/2165). Trauma service 
patients had the highest positive incidence at 23.5%. Demographic data for the 2,165 patients 
included in the final sample are provided in Table 1. 
Discussion 
Our study showed a low prevalence of positive asymptomatic COVID-19 screens 
(0.79%), a rate similar to a preprocedural screening program in the state of Washington (0.8%)
8
and substantially lower than the 5-80% range reported in an international review.
9
 However, it is
worth noting that Indiana was on a downward trend with COVID-19 incidence, decreasing from 
15% to 8.1% during the time of the study.
10
 Despite low incidence of asymptomatic positive
cases, our organization continued the preprocedural screening program due to informal feedback 
indicating proceduralist buy-in, enhanced sense of safety, and improved throughput. While 
universal COVID-19 screening might be ideal, this approach may have unintended 
consequences. For organizations with high surgical volumes, universal screening may increase 
costs, cause scheduling challenges, and likely put additional strain on testing resources for the 
hospital. Organizations should thus consider whether universal screening will produce high 
enough yield to offset economic and logistical consequences. 
This study had limitations concerning generalizability and data analysis. It was conducted 
at an academic health center in Indiana, limiting generalizability to other settings and states with 
higher incidence. For example, when this study was conducted, Indiana was on the lower end of 
case rate per 100,000 (1,611) compared to states with higher rates such as Louisiana (3,431) and 
Florida (3,114).
1
 In addition, the data analysis focus was descriptive, thus limiting conclusions
about relationships or causality, or the effects of this program on healthcare worker safety.  
Our study validated the value of the preprocedural screening program in allowing the 
resumption of elective surgical procedures. It was further strengthened through procedural team 
adoption and sustainment. Findings may help inform decision making of like organizations 
attempting to enhance safety while resuming elective procedures. 
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Total 17 (0.79) 2148 (99.21%) 2165 
Age 
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      Hispanic 
      Non-Hispanic (NH) White 
      NH Black/African American 
      NH American Indian/Alaska Native 
      NH Asian 
      NH Native Hawaiian/other Pacific Island 



















      Anesthesia 
      Cardiology 
      Cardiovascular  
      Ear, Nose and Throat 
      Gastroenterology 
      Neurosurgery 
      Obstetrics & Gynecology 
      Ophthalmology 
      Oral Maxillofacial Surgery & Dentistry 
      Orthopedics 
      Peripheral Vascular 
      Plastic Surgery 
      Podiatry 
      Pulmonology Critical Care Medicine 
      Radiology 
      General Surgery 
      Thoracic 
      Transplant 
      Urology 
1 (5.88) 
3 (17.56) 
1 (5.88) 
2 (11.76) 
1 (5.88) 
2 (11.76) 
2 (11.76) 
2 (11.76) 
2 (11.76) 
1 (5.88) 
4 (0.19) 
18 (0.84) 
61 (2.84) 
103 (4.80) 
294 (13.69) 
125 (5.82) 
148 (6.89) 
2 (0.09) 
23 (1.07) 
281 (13.08) 
74 (3.45) 
38 (1.77) 
5 (0.23) 
86 (4.00) 
176 (8.19) 
340 (15.83) 
41 (1.91) 
78 (3.63) 
251 (11.69) 
5 (0.23) 
21 (0.97) 
62 (2.86) 
103 (4.76) 
296 (13.67) 
126 (5.82) 
150 (6.93) 
2 (0.09) 
23 (1.06) 
283 (13.07) 
74 (3.42) 
40 (1.85) 
5 (0.23) 
86 (3.97) 
178 (8.22) 
341 (15.75) 
41 (1.89) 
78 (3.60) 
251 (11.59) 
